Interestingly, since we know that MTHFD2 can favor cancer progression through various mechanisms, such as providing metabolites for nucleotide synthesis, maintaining epigenetic homeostasis or promoting cell cycle progression, further research should address whether the combination of MTHFD2 inhibition with the inhibition of some of these mechanisms could synergistically boost cancer cell death. Here, MTHFD2 is linked to cancer.